EMEA-001129-PIP01-11-M05
Key facts
Invented name |
Plegridy
|
Active substance |
peginterferon beta-1a
|
Therapeutic area |
Neurology
|
Decision number |
P/0359/2022
|
PIP number |
EMEA-001129-PIP01-11-M05
|
Pharmaceutical form(s) |
Solution for injection
|
Condition(s) / indication(s) |
Treatment of multiple sclerosis
|
Route(s) of administration |
|
Contact for public enquiries |
Biogen Idec Ltd
Tel. +44 (0)1628 501000 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|